Point source concentration of GDNF may explain failure of phase II clinical trial

Publisher Website

7 September 2006

journal article
research article
Published by Elsevier BV in Experimental Neurology

Vol. 202 (2), 497-505
https://doi.org/10.1016/j.expneurol.2006.07.015

Abstract

No abstract available

Keywords

Cited by 215 articles